Dr. Janis K. Fraser is a Principal at Fish & Richardson P.C., one of the top intellectual property law firms in the world. Since joining Fish & Richardson in 1989, she has helped the firm's biotechnology patent practice grow to its current preeminent position. Her multi-million dollar practice spans all aspects of biotechnology and pharmaceutical chemistry patent law, including patent prosecution, due diligence, freedom-to-operate analyses, and strategic advice. Dr. Fraser's clients include AstraZeneca, Biogen Idec, Genzyme, Chugai, Massachusetts General Hospital, Beth Israel Deaconess Medical Center, the Dana Farber Cancer Institute, and numerous other biotech, pharmaceutical and venture capital companies and academic institutions around the world.
Named to "The Top 10 Lawyers" list published in the March 2005 issue of Women's Business Boston, Dr. Fraser frequently lectures on the subject of biotechnology and pharmaceutical patent law. She co-wrote and edited a two-volume coursebook on the subject, and continues to co-write and edit annual updates. Dr. Fraser holds a Ph.D. in Biochemistry from MIT and a J.D. from Harvard Law School.
Principal
Fish & Richardson P.C.
